肾移植缺血再灌注损伤的促血栓炎症反应与移植结局
这项前瞻性队列研究纳入63例活体(26例)和遗体(37例)供肾移植受者,在再灌注后1、10、30分钟从移植肾静脉及体循环采血检测IIIS级联系统激活产物。遗体供肾再灌注后迅速出现三种级联系统联动激活,sC5b-9与移植物功能障碍相关;活体供肾无此反应,HMP保存与减轻血栓炎症及保护中期肾功能相关。
要点
- 遗体供肾再灌注后迅速发生局部血栓炎症反应,活体供肾无此反应。
- 补体激活产物sC5b-9与移植肾功能短期及24个月功能障碍强相关。
- 低温机器灌注(HMP)与减轻血栓炎症及保护中期肾功能相关。
核心结论
- 遗体供肾对缺血再灌注损伤易发生迅速的血栓炎症反应,对移植物短期和长期功能均不利。
研究设计与样本
- 前瞻性队列研究纳入63例肾移植患者,其中活体供肾26例、遗体供肾37例。
- 在基线体循环及再灌注后1、10、30分钟移植肾静脉局部采血,检测激肽释放酶-激肽、凝血和补体系统激活产物。
主要发现
- 遗体供肾再灌注后三种IIIS级联系统迅速且联动激活,提示强烈的局部血栓炎症反应。
- 补体激活产物sC5b-9与其他IIIS激活标志物强相关,并与短期及中期(24个月)移植物功能障碍强相关。
- 活体供肾未表现出血栓炎症反应。
- 使用HMP与减轻血栓炎症及保护中期肾功能相关。
临床怎么用
- 遗体供肾移植需关注再灌注后局部血栓炎症反应对移植结局的影响。
- HMP保存可能有助于减轻血栓炎症并保护中期肾功能。
- sC5b-9或可作为评估移植物功能障碍风险的候选标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In kidney transplantation (KT), the role of the intravascular innate immune system (IIIS) in response to ischemia-reperfusion injury (IRI) is not well-understood. Here, we studied parallel changes in the generation of key activation products of the proteolytic cascade systems of the IIIS following living donor (LD) and deceased donor (DD) transplantation and evaluated potential associations with clinical outcomes. METHODS: In a cohort study, 63 patients undergoing LD (n = 26) and DD (n = 37) transplantation were prospectively included. Fifteen DD kidneys were preserved with hypothermic machine perfusion (HMP), and the remaining were cold stored. Activation products of the kallikrein-kinin, coagulation, and complement systems were measured in blood samples obtained systemically at baseline and locally from the transplant renal vein at 1, 10, and 30 minutes after reperfusion. RESULTS: DD kidneys exhibited a prompt and interlinked activation of all 3 cascade systems of IIIS postreperfusion, indicating a robust and local thrombo-inflammatory response to IRI. In this initial response, the complement activation product sC5b-9 exhibited a robust correlation with other IIIS activation markers and displayed a strong association with short-term and mid-term (24-month) graft dysfunction. In contrast, LD kidneys did not exhibit this thrombo-inflammatory response. The use of HMP was associated with reduced thromboinflammation and preserved mid-term kidney function. CONCLUSION: Kidneys from DD are vulnerable to a prompt thrombo-inflammatory response to IRI, which adversely affects both short-term and long-term allograft function. Strategies aimed at minimizing graft immunogenicity prior to reperfusion are crucial to mitigate the intricate inflammatory response to IRI.
引用
- Strandberg G, Öberg CM, Blom AM, et al. Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes. Kidney Int Rep. 2023. PMID: 38106604. doi:10.1016/j.ekir.2023.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。